ANVISA recently published the Collegiate Board Resolution (RDC) No. 865/2024, which regulates the exclusive electronic issuance of sanitary and other certificates. This measure represents a significant step forward in the digitalization of public services, bringing more agility, security, and cost savings for companies and professionals in the regulated sector.
In our new newsletter, the Life Sciences team analyzes the main points of the regulation, the documents covered, the practical impacts for companies, and the changes in the request and issuance process. We also discuss the legal validity of digital documents and the mechanisms adopted by ANVISA to ensure their authenticity.
This is a change that directly affects the routine of companies operating in sectors such as pharmaceuticals, cosmetics, food, and health products. It’s worth paying attention!
Read the full analysis here (available only in portuguese).
